However, the controversial, disappointing results observed in the scarce clinical trials that have tested SST analogs in the treatment of patients with breast cancer suggest that more studies are necessary to fully elucidate the exact role of SST and CORT in the development and/or progression of breast cancer, especially in the context of obesity. This evidence concerns the gene SST and obesity due to melanocortin 4 receptor deficiency.